Cargando…
Evaluation of Angiogenesis in Multiple Myeloma by VEGF Immunoexpression and Microvessel Density
Background Multiple myeloma (MM) is a plasma cell disorder characterized by monoclonal proliferation of plasma cells in bone marrow. Plasmablastic MM is a morphologic subset of MM, containing ≥2% plasmablasts of all plasma cells. Methods The study included 30 consecutively diagnosed patients of MM...
Autores principales: | Palta, Anshu, Kaur, Manveen, Tahlan, Anita, Dimri, Kislay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Private Ltd.
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419170/ https://www.ncbi.nlm.nih.gov/pubmed/32792792 http://dx.doi.org/10.1055/s-0040-1714933 |
Ejemplares similares
-
Immunoexpression of CD34, CD117, and p53 in Hypocellular Bone Marrow Disorders
por: Sharma, Pooja, et al.
Publicado: (2021) -
Clinical significance of microvessel density in multiple myeloma patients.
por: Ahn, M. J., et al.
Publicado: (2001) -
VEGF and CD 34: A correlation between tumor angiogenesis and microvessel density-an immunohistochemical study
por: Kukreja, Ipsita, et al.
Publicado: (2013) -
VEGF Immunoexpression in Prostate Adenocarcinoma
por: PĂNUŞ, ANDREI, et al.
Publicado: (2021) -
Adverse Prognostic Impact of Bone Marrow Microvessel Density in Multiple Myeloma
por: Lee, Nuri, et al.
Publicado: (2015)